Metastatic Hepatocellular Carcinoma Recruiting Phase 1 Trials for Paclitaxel (DB01229)

Also known as: Hepatocellular Carcinoma Metastatic / Metastatic hepatocellular carcinoma (disorder) / Metastatic hepatocellular carcinoma (morphologic abnormality) / Liver cell carcinoma / Primary liver cell carcinoma (disorder) / Hepatocellular carcinoma / Carcinoma hepatocellular / Hepatoma / Primary carcinoma of liver (disorder) / Liver carcinoma / Carcinoma liver / Liver cell carcinoma (disorder) / Hepatocellular carcinoma (morphologic abnormality) / Carcinoma of liver / Carcinoma, Hepatocellular

DBCOND0041971 (Metastatic Hepatocellular Carcinoma)Recruiting1 IdentifierTitlePurposeDrugs
NCT05092373Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or ThoraxTreatment
NCT05075993Study of LVGN3616 and LVGN6051┬▒LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsTreatment